Repligen completes acquisition of FlexBiosys Inc. on April 17, 2023

REPLIGEN CORP

Completed acquisition of all outstanding equity of FlexBiosys Inc. on April 17, 2023.
Equity Purchase Agreement signed April 12, 2023, with sellers TSAP Holdings, Gayle Tarry, and Stanley Tarry.
No deal value or financial terms disclosed in this filing.

item 8.01

REPLIGEN CORP filing history →

Source: SEC EDGAR

accession 0001193125-23-104254

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.